Geneviève Louason
- Co-authors
- Charles TheilletP SpeiserRobert ZeillingerFrank CourjalP SismondiJalila AdnaneJocelyne JacquemierMichel Longy
- Topics
- Cancer-related Molecular Pathways (4 papers)Cancer Genomics and Diagnostics (4 papers)RNA modifications and cancer (2 papers)
In The Last Decade
Geneviève Louason
8 papers receiving 395 citations
Peers
Comparison fields: 5 of 40
- Molecular Biology 246
- Oncology 207
- Cancer Research 107
- Genetics 90
- Cell Biology 56
Countries citing papers authored by Geneviève Louason
This map shows the geographic impact of Geneviève Louason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneviève Louason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneviève Louason more than expected).
Fields of papers citing papers by Geneviève Louason
This network shows the impact of papers produced by Geneviève Louason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneviève Louason. The network helps show where Geneviève Louason may publish in the future.
Co-authorship network of co-authors of Geneviève Louason
This figure shows the co-authorship network connecting the top 25 collaborators of Geneviève Louason. A scholar is included among the top collaborators of Geneviève Louason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geneviève Louason. Geneviève Louason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 160 | |
| 2 | DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours | 1 |
| 3 | 63 | |
| 4 | 6 | |
| 5 | Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients. | 19 |
| 6 | Quantification of ERBB2 protein expression in breast cancer: three levels of expression defined by their clinico-pathological correlations. | 7 |
| 7 | 131 | |
| 8 | 13 |
About Geneviève Louason
Geneviève Louason is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 8 papers that have together received 400 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cancer Genomics and Diagnostics (4 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (207 citations), Cancer Research (107 citations) and Reproductive Medicine (48 citations). Geneviève Louason has collaborated with scholars based in France, Italy and Austria. Frequent co-authors include Charles Theillet, P Speiser, Robert Zeillinger, Frank Courjal, P Sismondi, Jalila Adnane, Jocelyne Jacquemier, Michel Longy, Patrick Gaudray and Daniel Birnbaum. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.